权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mechanisms regulating KSHV transcription elongation and termination

KSHV 转录延伸和终止的调节机制

基本信息

批准号：
10426345
负责人：
NICHOLAS K CONRAD
金额：
$ 46.88万
依托单位：
UT SOUTHWESTERN MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-06-10 至 2026-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10426345
关键词：
Address Affect Binding Binding Proteins Biological Assay CRISPR screen Cell Nucleus Cells Complement Coupled DNA Polymerase II DNA Viruses DNA-Directed RNA Polymerase Data Data Analyses Disease ENG gene Elongation Factor Gene Expression Genes Genetic Transcription Goals Herpesviridae Human Human Herpesvirus 8 Infection Integration Host Factors Introns Kaposi Sarcoma Lead Life Cycle Stages Light Link Lymphoma cell Lytic Lytic Phase Mediating Messenger RNA Methods Modeling Molecular Molecular Biology Monitor Multicentric Angiofollicular Lymphoid Hyperplasia Mus Nuclear Oncogenic Viruses Pathogenesis Patients Phenotype Phosphorylation Play Poly A Post-Transcriptional Regulation Production Protein Dephosphorylation Protein phosphatase Proteins Publishing RNA RNA Binding RNA Splicing Regulation Regulator Genes Reporter Genes Reporting Role Running Signal Transduction Small Interfering RNA Speed System Testing Transcription Elongation Transcriptional Regulation Viral Viral Genes Viral Genome Virion Virus Work combat comparative density experimental study gammaherpesvirus genome-wide genome-wide analysis human pathogen insight knock-down lytic gene expression lytic replication novel pathogen pathogenic virus primary effusion lymphoma promoter reactivation from latency transcription termination transcriptome sequencing viral RNA

项目摘要

PROJECT SUMMARY/ABSTRACT Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic virus that causes Kaposi’s sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman’s disease (MCD). Like all herpesviruses, the KSHV life cycle consists of latent and lytic phases, and the virus relies on a sophisticated cascade of gene expression during lytic reactivation from latency. KSHV uses the host cell gene expression machinery to transcriptionally and posttranscriptionally control the timing and levels of gene expression. For host genes, proper transcription involves regulation of RNA polymerase II (pol II) elongation illustrated by pol II pausing at the 5´ and 3´ ends of genes. The near ubiquitous regulation of pol II elongation on host genes coupled with KSHV’s use of the host machinery suggest that the virus employs similar mechanisms of regulation. Despite this potential importance of pol II control by elongation, regulation of KSHV transcription elongation has been largely unexplored. Using an unbiased genome-wide CRISPR screen, host factors involved in pol II elongation and mRNA 3´ end formation were identified as negative regulators of KSHV gene expression. Depletion of these factors in cells latently infected with a KSHV infectious bacmid clone (BAC16) robustly increases the speed and overall production of infectious virions upon lytic reactivation. In the proposed work, the mechanisms linking elongation and 3´-end formation factors to KSHV transcription will be defined. Aim 1 will explore the importance of these elongation factors in PEL cells and during lytic gammaherpesvirus infection. Aim 2 uses viral gene reporter constructs and reductionist molecular biology to test whether pol II pausing is induced by cellular factors on viral genes. Moreover, the cis-acting and trans-acting requirements for elongation control of viral genes will be determined. In Aim 3, a combination of high-throughput methods will be performed to examine the roles of host elongation factors on viral gene expression. These will include RNA-seq to test gene expression levels, PAC-seq to address mRNA 3´-end formation, and PRO-seq to determine pol II occupancy on the viral genome. Finally, preliminary and published data suggest that reversible phosphorylation of elongation factors may play essential roles in the control of pol II pausing. In Aim 4, the targets and role of dephosphorylation of elongation factors on KSHV genes will be defined. Successful completion of the proposed studies will have considerable impact on the field by defining a novel host factor that negatively regulates viral gene expression by a previously undescribed mechanism(s). Moreover, it is likely that the mechanisms described will apply to additional DNA viruses and inform human gene expression as well. These studies will generate a deeper understanding of the mechanisms of a pathogenic virus which may lead to insights into how to combat KSHV related diseases.

项目总结/文摘